Consensus Bath & Body Works, Inc.

Equities

BBWI

US0708301041

Market Closed - Nyse 04:00:02 2024-06-07 pm EDT 5-day change 1st Jan Change
45.84 USD -1.14% Intraday chart for Bath & Body Works, Inc. -11.74% +6.21%

Evolution of the average Target Price on Bath & Body Works, Inc.

Price target over the last 5 years

History of analyst recommendation changes

a41001b8ba0ea87e740baf1c20b514d.frQzzHRFgb-mDUDiwmjnIv_-M9L8FXarhFAwhaVv9pA.J-Nw9QYv9vuQPwKYjUWiW7HMVYaYRiX73R9H6Ognn-FNxFqkOxq40MNjAQ~41e95dbf24d84645f803c5ddff461c5f
BMO Capital Adjusts Price Target on Bath & Body Works to $55 From $50, Keeps Outperform Rating MT
Goldman Sachs Adjusts Price Target on Bath & Body Works to $60 From $56, Keeps Buy Rating MT
Piper Sandler Adjusts Bath & Body Works' Price Target to $47 From $45, Keeps Neutral Rating MT
Social Buzz: Wallstreetbets Stocks Mostly Lower Pre-Bell Tuesday; AMC Entertainment to Decline, Bath & Body Works to Open Higher MT
Deutsche Bank Raises Price Target on Bath & Body Works to $57 From $53 MT
JPMorgan Upgrades Bath & Body Works to Neutral From Underweight, Adjusts Price Target to $53 From $40 MT
Morgan Stanley Raises Price Target on Bath & Body Works to $56 From $52, Adds 'Top Pick' Label, Keeps Overweight Rating MT
Wells Fargo Adjusts Bath & Body Works' Price Target to $48 From $42, Keeps Equalweight Rating MT
Piper Sandler Raises Price Target on Bath & Body Works to $45 From $44, Maintains Neutral Rating MT
Goldman Sachs Raises Price Target on Bath & Body Works to $56 From $49, Maintains Buy Rating MT
UBS Raises Bath & Body Works Price Target to $52 From $46, Maintains Neutral Rating MT
Deutsche Bank Adjusts Bath & Body Works Price Target to $53 From $55, Maintains Buy Rating MT
Telsey Advisory Adjusts Bath & Body Works' Price Target to $53 From $50, Maintains Outperform Rating MT
TD Cowen Raises Price Target on Bath & Body Works to $55 From $35, Keeps Outperform Rating MT
Evercore ISI Raises Bath & Body Works Price Target to $45 From $30, Maintains In Line Rating MT
Deutsche Bank Adjusts Bath & Body Works Price Target to $55 From $49, Maintains Buy Rating MT
UBS Adjusts Bath & Body Works Price Target to $46 From $44, Maintains Neutral Rating MT
Morgan Stanley Boosts Price Target on Bath & Body Works to $52 From $50, Keeps Overweight Rating MT
UBS Raises Price Target on Bath & Body Works to $44 From $34, Keeps Neutral Rating MT
Barclays Downgrades Bath & Body Works to Equalweight From Overweight, Raises Price Target to $45 From $37 MT
Wells Fargo Raises Bath & Body Works' Price Target to $40 From $35, Keeps Equalweight Rating MT
Goldman Sachs Trims Price Target on Bath & Body Works to $49 From $52, Keeps Buy Rating MT
Deutsche Bank Cuts Bath & Body Works Price Target to $44 From $47, Maintains Buy Rating MT
Telsey Advisory Group Cuts Bath & Body Works Price Target to $42 From $52, Maintains Outperform Rating MT
UBS Cuts Bath & Body Works Price Target to $34 From $39, Maintains Neutral Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
45.84 USD
Average target price
53.11 USD
Spread / Average Target
+15.86%
High Price Target
70 USD
Spread / Highest target
+52.71%
Low Price Target
42 USD
Spread / Lowest Target
-8.38%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Bath & Body Works, Inc.

BMO Capital
Goldman Sachs
Piper Sandler
Deutsche Bank Securities
JPMorgan Chase
Morgan Stanley
Wells Fargo Securities
UBS
Telsey Advisory Group
TD Cowen
Evercore ISI
Barclays
Jefferies & Co.
Raymond James
Citigroup
Argus
Credit Suisse
Cowen
Baird
BofA Securities
B. Riley
MKM Partners
Atlantic Equities
Morningstar
RBC Capital Markets
J.P. Morgan Chase
KeyBanc Capital Markets
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
  1. Stock Market
  2. Equities
  3. BBWI Stock
  4. Consensus Bath & Body Works, Inc.